Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary.
about
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studiesAshkenazi Jews and breast cancer: the consequences of linking ethnic identity to genetic diseaseHigh proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague areaPrevalence of the most frequent BRCA1 mutations in Polish populationRetrospective analysis of clinicopathological characteristics and family history data of early-onset breast cancer: a single-institutional study of Hungarian patients.Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families.Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancerOn the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations.Improved survival in BRCA2 carriers with ovarian cancerFounder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control.High prevalence of BRCA1 stop mutation c.4183C>T in the Tyrolean population: implications for genetic testingHigh frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients.The contribution of BRCA1 and BRCA2 to ovarian cancer.Epidemiology of ovarian cancer: a review.BRCA1 and BRCA2 mutations in the ovarian cancer population across race and ethnicity: special reference to Asia.A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.Hereditary ovarian cancer in Poland.BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.Mutations in context: implications of BRCA testing in diverse populations.Prevalence of founder BRCA1 and BRCA2 mutations in unselected French Canadian women with breast cancer.Prevalence of two BRCA1 mutations, 5382insC and 300T > G, in ovarian cancer patients from Ukraine.Prevalence of deleterious mutations among patients with breast cancer referred for multigene panel testing in a Romanian population.RAD51C is a susceptibility gene for ovarian cancer
P2860
Q24531993-2D8A5A83-7610-4E98-9265-E2AB515669CCQ24675652-58947526-0876-4ACD-A71F-088E931F21ACQ24813558-28B473CF-987B-466E-8FB3-E7FB0C817ED3Q28390186-A16B84B5-3727-479B-ADAA-D7911D24E331Q30633035-4B6AF203-FB7F-4E82-A730-9DBDBE16A69AQ33368443-B5210743-30AA-40E3-AE96-3E8B6519A5BBQ34113283-EBD08F53-9C90-494C-8427-9D34F894C17FQ34705352-342CFE94-9AF3-4DD9-BB62-3F1681DEE2E0Q35828679-C4050BBE-7F64-4414-8895-034E49E8CFE6Q36117690-CB691D6E-BDA5-42EE-9D39-D8D3E61C7132Q36474986-C44D03EA-F804-46F2-BF5B-A5DE41143D58Q37147699-9A1A4C65-4739-4100-A940-9361A79F1848Q37453854-E7432AAD-1C25-4979-BD67-A1EBEFCB33F1Q37720438-39FB7092-A4B8-4560-8366-EB688BB71758Q38077900-02B5B736-DB1A-41B7-9439-86A07FB208E7Q42181679-A1D772C7-9ED4-42D9-8234-DC1B384DF351Q43683502-652A446B-D40F-4CC9-8031-866C72A5645EQ44221699-4D41B724-FD69-4CDE-8F79-901E5E1F4F53Q47691368-F687AD2D-0D80-45D9-AA8D-5ABEEE37F036Q49210867-3C64AEED-EC57-486E-9372-FC8BF9B41896Q50849096-95980702-39BD-46A4-8489-0E41AE53D804Q55280273-BEEC39D7-5755-47F7-9498-16C01E14179DQ57306209-8839CAFB-FE7E-474C-8F95-05CCB432D2ED
P2860
Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Prevalence of founder BRCA1 an ...... an cancer patients in Hungary.
@ast
Prevalence of founder BRCA1 an ...... an cancer patients in Hungary.
@en
type
label
Prevalence of founder BRCA1 an ...... an cancer patients in Hungary.
@ast
Prevalence of founder BRCA1 an ...... an cancer patients in Hungary.
@en
prefLabel
Prevalence of founder BRCA1 an ...... an cancer patients in Hungary.
@ast
Prevalence of founder BRCA1 an ...... an cancer patients in Hungary.
@en
P2093
P2860
P1476
Prevalence of founder BRCA1 an ...... an cancer patients in Hungary.
@en
P2093
I Besznyak
M Van Der Looij
P2860
P304
P356
10.1002/(SICI)1097-0215(20000601)86:5<737::AID-IJC21>3.0.CO;2-1
P577
2000-06-01T00:00:00Z